Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning

This publication has 23 references indexed in Scilit:

• Management of CMV infections: recommendations from the infectious diseases working party of the EBMT
  Bone Marrow Transplantation, 2004
• Minimal GVHD following in-vitro Tcell–depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors
  Experimental Hematology, 2003
• β‐Herpesvirus Challenges in the Transplant Recipient
  The Journal of Infectious Diseases, 2002
• Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture?
  Current Opinion in Infectious Diseases, 2002
• Area under the viraemia curve versus absolute viral load: Utility for predicting symptomatic cytomegalovirus infections in kidney transplant patients
  Journal of Medical Virology, 2001
• Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome
  Bone Marrow Transplantation, 2001
• Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation
  The Lancet, 2000
• Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
  Journal of Clinical Oncology, 1998
• Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
  Blood, 1998
• Ganciclovir
  New England Journal of Medicine, 1996